The common interests of Duke Cancer Institute’s Brain and Spinal Cord Tumors group are primary malignant brain tumors of adults and children.
Compared to other cancers, brain and spinal cord cancers are relatively rare. Malignant brain and spinal cord tumors are likely to grow quickly and spread into other parts of the brain. The chance of recovery depends on many factors, including age, tumor size, tumor type, and where the tumor is in the central nervous system.
The Preston Robert Tisch Brain Tumor Center continues to lead the nation in having the largest clinical brain tumor service seeing between 800 and 900 new brain tumor patients annually from 50 states and 5 countries.
To make an appointment, please call 919.684.5301. To find a doctor, visit Find A Specialist.
Our research activities include:
We design and execute Phase I, Phase II, and Phase III clinical trials in primary and metastatic brain and spinal cord tumors in adults and children, based on laboratory discoveries within our program, and also execute clinical trials for improvement of quality of life in brain and spinal cord tumor patients. SEARCH OUR CLINICAL TRIALS
Tom O’Donnell, 53, might be proof that not every superhero wears a cape. A manager at Walgreens by day, he appears to be your average, middle-aged man, with his only obvious distinction being a long scar, left by his nemesis, engraved across the right side of his shaven head. The scar eventually became his signature mark, perceived by his friends and family as a symbol of one man’s journey from ordinary to extraordinary. More.
Duke Cancer Institute constellates the world-class resources of Duke University, Duke Health and the Duke Comprehensive Cancer Center into a collaborative powerhouse. We are poised to drive a paradigm shift in the way long-established cancer centers and institutes have been waging this war.Learn More